Seegene, Inc. (KOSDAQ:096530)

South Korea · Delayed Price · Currency is KRW

26,600

-1,950 (-6.83%)

Jul 20, 2026, 3:30 PM KST

-17.65% (1Y)

Market Cap	1.21T -18.6%
Revenue (ttm)	487.37B +10.7%
Net Income	65.66B +515.9%
EPS	1,425.76 +517.3%
Shares Out	45.56M
PE Ratio	18.66
Forward PE	14.67
Dividend	1,000.00 (3.50%)
Ex-Dividend Date	Jun 29, 2026

Volume	216,501
Open	28,100
Previous Close	28,550
Day's Range	26,500 - 28,200
52-Week Range	21,700 - 32,800
Beta	0.90
Analysts	Buy
Price Target	44,500.00 (+67.29%)
Earnings Date	Aug 7, 2026

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de... [Read more]

Industry Medical - Specialties

Sector Healthcare

Founded 2000

Employees 216

Stock Exchange KOSDAQ

Ticker Symbol 096530

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 096530 stock is "Buy." The 12-month stock price target is ₩44,500, which is an increase of 67.29% from the latest price.

Price Target

₩44,500

(67.29% upside)

Analyst Consensus: Buy

Stock Forecasts